KIMS Hospital Bengaluru commences operations at PES University campus
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Clinical trial enrollment has long been a bottleneck in drug development
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
Subscribe To Our Newsletter & Stay Updated